304 related articles for article (PubMed ID: 32820849)
21. A Review on Pityriasis Rubra Pilaris.
Wang D; Chong VC; Chong WS; Oon HH
Am J Clin Dermatol; 2018 Jun; 19(3):377-390. PubMed ID: 29302927
[TBL] [Abstract][Full Text] [Related]
22. Refractory pityriasis rubra pilaris with good response after treatment with ustekinumab.
Aragón-Miguel R; Prieto-Barrios M; Calleja-Algarra A; Velasco-Tamariz V; Andres-Lencina JJ; Ortiz-Romero P; Monsálvez-Honrubia V
J Dtsch Dermatol Ges; 2018 Aug; 16(8):1022-1025. PubMed ID: 29947473
[No Abstract] [Full Text] [Related]
23. [Erythroderma after corticosteroid withdrawal in papulosquamous dermatosis in children. Diagnosis: pityriasis rubra pilaris, classic juvenile type].
Terheyden P; Hofmann UB; Hamm H; Bröcker EB
Hautarzt; 2001 Nov; 52(11):1058-61. PubMed ID: 11757463
[No Abstract] [Full Text] [Related]
24. Identification of a pathogenic
Nielsen RM; Gram SB; Bygum A
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33431438
[TBL] [Abstract][Full Text] [Related]
25. Pityriasis rubra pilaris treatment options: A retrospective case series from a tertiary hospital.
Ringin S; Baker CS; Foley P; Daniel BS
Dermatol Ther; 2021 Nov; 34(6):e15128. PubMed ID: 34505752
[TBL] [Abstract][Full Text] [Related]
26. Acantholytic pityriasis rubra pilaris associated with topical use of imiquimod 5%: case report and literature review.
Leite OG; Tagliolatto S; Souza EM; Cintra ML
An Bras Dermatol; 2020; 95(1):63-66. PubMed ID: 31789270
[TBL] [Abstract][Full Text] [Related]
27. Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab.
Lu R; George SJ; Hsu S
Dermatol Online J; 2006 May; 12(4):18. PubMed ID: 17083873
[No Abstract] [Full Text] [Related]
28. Case of pityriasis rubra pilaris progressed to generalized erythroderma following blockade of interleukin-17A, but improved after blockade of interleukin-12/23 p40.
Matsuda T; Yamazaki F; Ueda-Hayakawa I; Kambe N; Okamoto H
J Dermatol; 2019 Jan; 46(1):70-72. PubMed ID: 30506728
[TBL] [Abstract][Full Text] [Related]
29. [Pityriasis rubra pilaris. Case reports and review of the literature].
Artik S; Megahed M; Ruzicka T
Hautarzt; 2003 Sep; 54(9):858-63. PubMed ID: 12955264
[TBL] [Abstract][Full Text] [Related]
30. Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris.
Feldmeyer L; Mylonas A; Demaria O; Mennella A; Yawalkar N; Laffitte E; Hohl D; Gilliet M; Conrad C
JAMA Dermatol; 2017 Apr; 153(4):304-308. PubMed ID: 28122069
[TBL] [Abstract][Full Text] [Related]
31. Type I pityriasis rubra pilaris treated with tumor necrosis factor inhibitors, ustekinumab, or secukinumab: A review.
Maloney NJ; Hisaw LD; Worswick S
J Am Acad Dermatol; 2018 Sep; 79(3):585-587. PubMed ID: 29518460
[No Abstract] [Full Text] [Related]
32. Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin.
Chastagner M; Hoelt P; Kanitakis J; Jullien D; Villani AP
Eur J Dermatol; 2019 Apr; 29(2):218-220. PubMed ID: 30827945
[No Abstract] [Full Text] [Related]
33. [Pityriasis rubra pilaris].
Wollina U
Hautarzt; 2012 Aug; 63(8):655-61; quiz 662. PubMed ID: 22825756
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic hotline. Treatment of pityriasis rubra pilaris with etanercept.
Guedes R; Leite L
Dermatol Ther; 2011; 24(2):285-6. PubMed ID: 21410618
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of ustekinumab and guselkumab in treatment refractory pityriasis rubra pilaris: A case series.
Pham JP; Allen N; Smith A
Australas J Dermatol; 2022 Nov; 63(4):522-524. PubMed ID: 36129444
[No Abstract] [Full Text] [Related]
36. [Pityriasis rubra pilaris].
Quenan S; Laffitte E
Ann Dermatol Venereol; 2018 Jan; 145(1):50-59. PubMed ID: 29290415
[TBL] [Abstract][Full Text] [Related]
37. Pityriasis rubra pilaris sensitive to narrow band-ultraviolet B light therapy.
Vergilis-Kalner IJ; Mann DJ; Wasserman J; Petronic-Rosic V; Tsoukas MM
J Drugs Dermatol; 2009 Mar; 8(3):270-3. PubMed ID: 19271375
[TBL] [Abstract][Full Text] [Related]
38. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient.
Gómez M; Ruelas ME; Welsh O; Arcaute HD; Ocampo-Candiani J
J Drugs Dermatol; 2007 Mar; 6(3):337-9. PubMed ID: 17373198
[TBL] [Abstract][Full Text] [Related]
39. Pityriasis rubra pilaris.
White KL
Dermatol Online J; 2003 Oct; 9(4):6. PubMed ID: 14594579
[TBL] [Abstract][Full Text] [Related]
40. Pityriasis rubra pilaris: evolution of challenges in promising treatment options.
Sehgal VN; Srivastava G; Verma P
Skinmed; 2012; 10(1):18-23. PubMed ID: 22324172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
